
TSE:CCL.B
This summary was created by AI, based on 4 opinions in the last 12 months.
CCL Industries (CCL.B-T) is receiving mixed reviews from experts in the investment community. While some note a lack of a strong multi-year thesis for growth, others highlight the company's robust Q3 results and its proactive approach to acquisitions and share buybacks. This trend of expansion, coupled with a clean balance sheet, positions CCL favorably for future performance. The company's ability to generate organic growth and enhance shareholder value through dividends and strategic acquisitions is acknowledged positively. Analysts maintain a price target of $92.55, reflecting optimism about the firm's continued success in diverse markets, particularly within the label manufacturing sector.
He does not know the details of how they are going to split it. There is research that shows there is a perception that you can buy more shares after a split. This is a human condition. There is nothing beneficial in fundamentals. Trade it if you want but because you like the company and then own it post-split, but don’t buy it just because it is going to split.
In containers, plastics and packaging. Very profitable. It has grown earnings at a torrid pace, 40%+ compound growth rate over the last 5 years. Trading at about 20X earnings. They just closed on the acquisition of Innovia, which is quite profitable and has some very attractive segments such as polymer banknotes, which are very under penetrated globally at about only 3%. Dividend yield of 0.8%. (Analysts’ price target is $325.)
It does nothing fancy. It is the world’s largest manufacturer of pressure sensitive labels as well as aerosol cans. They are good at what they do. They did some very strategic and opportunistic acquisitions over the years. They raise their dividend over the years and he continues to buy it for clients.
A tremendous allocator of capital. They’ve made some great acquisitions. This is the world’s largest maker of specialty labels. They make banknotes, a very specialized product. Have grown both organically and through acquisitions. Dividend yield of 0.8%. (Analysts’ price target is $337.50.)